title: Clinical profile, genotype and management updates of hepatitis B virus.
abstract: Hepatitis B virus (HBV) is a well known agent of acute and chronic hepatitis, liver cirrhosis and hepatocellular carcinoma. Around 400 million people worldwide carrier of HBV of which more than 250 million reside in Asia, and 1-2 million people have died from it. It has a partially double-stranded DNA, having 3.2-kb genome size and replicate via reverse transcription of RNA intermediate. In the natural history or during the antiviral therapy of chronic HBV infection, seroconversion from HBeAg to anti-HBeAg is usually accompanied by a decrease in viral replication and remission of liver disease. Based on genomic sequence data HBV is classified into eight genotypes A-H and four major serotypes ayw, ayr, adw and adr on the basis of complete genome and S gene sequence analysis. Genotypes and serotypes are useful tools in understanding the epidemiology of HBV infection. HBV genotypes have distinct geographical distributions. The HBV variants appear during HBeAg seroconversion and they bring mutations in the precore region (PC) that prevent HBeAg synthesis. Another common HBeAg variant is the basal core promoter mutant (BCP) characterized by point mutation in the promoter of both HBeAg mRNA and core protein mRNA. The most frequent core promoter mutation is the double A1762T and G1764A nucleotide exchange, which results in a substantial decrease in HBeAg expression but enhanced viral genome replication. The approved antiviral drugs such as Interferon, lamivudine, adefovir dipivoxil, entecavir and telbivudine for purpose of treating chronic HBV infection is to prevent or stop the progression of liver injury by suppressing viral replication or eliminating infection. Sustained losses of viral markers of active viral replication (HBeAg and HBV DNA) are the standard end point of the therapies.
authors: Centre for Biotechnology, Allahabad Central University, Allahabad, India ; Department of Gastroenterology, MLN Medical College, Allahabad, India.
authors: Ajay
authors: A
authors: Kumar
authors: Manisha
authors: M
authors: Dwivedi
authors: S P
authors: SP
authors: Misra
authors: Sushil
authors: S
authors: Narang
authors: Balesh Kumar
authors: BK
authors: Tiwari
authors: Renu
authors: R
authors: Pandey
references: Indian J Gastroenterol. 2003 Jul-Aug;22(4):132-7
references: 12962435
references: Int J Cancer. 2002 Jul 1;100(1):86-91
references: 12115592
references: World J Gastroenterol. 2007 Jan 7;13(1):22-38
references: 17206752
references: Vox Sang. 1999;77(1):6-10
references: 10474084
references: N Engl J Med. 2002 Jul 18;347(3):168-74
references: 12124405
references: Indian J Med Res. 1991 Nov;93:337-9
references: 1797638
references: BMJ. 1998 Oct 17;317(7165):1034
references: 9841038
references: Arch Intern Med. 1990 May;150(5):1051-4
references: 2158773
references: J Hepatol. 2003;38 Suppl 1:S90-103
references: 12591188
references: Nat Med. 2005 Nov;11(11):1167-9
references: 16258538
references: Hepatology. 1998 Dec;28(6):1669-73
references: 9828233
references: J Med Virol. 2003 Mar;69(3):324-30
references: 12526041
references: Virology. 1997 Aug 18;235(1):104-8
references: 9300041
references: Semin Liver Dis. 1989 Nov;9(4):235-9
references: 2481341
references: Aliment Pharmacol Ther. 2007 Dec;26 Suppl 2:171-82
references: 18081660
references: Hepatology. 1987 Jul-Aug;7(4):758-63
references: 3301618
references: J Gastroenterol Hepatol. 2002 Dec;17 Suppl 3:S333-7
references: 12472959
references: Lancet. 2000 Apr 22;355(9213):1382-4
references: 10791517
references: J Hepatol. 1995;22(1 Suppl):52-6
references: 7602078
references: Ann Intern Med. 2000 May 2;132(9):723-31
references: 10787366
references: Hepatology. 2003 Apr;37(4):756-63
references: 12668967
references: N Engl J Med. 1999 Oct 21;341(17):1256-63
references: 10528035
references: J Commun Dis. 1989 Jun;21(2):139-41
references: 2809149
references: J Hepatol. 2003;39 Suppl 1:S111-5
references: 14708688
references: Antimicrob Agents Chemother. 2004 Sep;48(9):3498-507
references: 15328117
references: Indian Pediatr. 2002 Jul;39(7):625-31
references: 12147887
references: Digestion. 1995;56(2):85-95
references: 7750674
references: J Viral Hepat. 2004 Mar;11(2):97-107
references: 14996343
references: Rev Gastroenterol Disord. 2007 Spring;7(2):63-73
references: 17597674
references: J Viral Hepat. 2005 Mar;12(2):111-24
references: 15720525
references: J Hepatol. 2008 Mar;48(3):391-8
references: 18199519
references: J Viral Hepat. 2003 Jul;10(4):298-305
references: 12823597
references: J Virol. 1974 Aug;14(2):384-91
references: 4847328
references: Indian Pediatr. 2007 Sep;44(9):663-74
references: 17921555
references: Antivir Chem Chemother. 2001;12 Suppl 1:119-29
references: 11594678
references: Clin Pharmacokinet. 1999 Jan;36(1):41-66
references: 9989342
references: J Hepatol. 1993 Jul;18(3):342-52
references: 8228128
references: Gut. 1996;38 Suppl 2:S56-9
references: 8786056
references: J Gen Virol. 1995 Dec;76 ( Pt 12):3159-64
references: 8847524
references: Lancet. 1989 Sep 9;2(8663):588-91
references: 2570285
references: J Hepatol. 2007 Apr;46(4):719-26
references: 17316876
references: J Gastroenterol Hepatol. 2002 Feb;17(2):165-70
references: 11966946
references: Gastroenterology. 2005 Aug;129(2):528-36
references: 16083710
references: Indian J Med Res. 2005 May;121(5):670-5
references: 15937371
references: N Engl J Med. 2006 Mar 9;354(10):1011-20
references: 16525138
references: World J Gastroenterol. 2007 Dec 14;13(46):6150-5
references: 18069753
references: J Med Virol. 2006 Jan;78(1):53-9
references: 16299727
references: Am J Med Sci. 2003 Jun;325(6):349-62
references: 12811231
references: N Engl J Med. 1997 Dec 11;337(24):1733-45
references: 9392700
references: N Engl J Med. 2007 Dec 20;357(25):2576-88
references: 18094378
references: World J Gastroenterol. 2006 Nov 7;12(41):6702-6
references: 17075988
references: Hepatology. 2001 Sep;34(3):578-82
references: 11526545